Showing 1 - 20 results of 1,789 for search '"xanthine"', query time: 0.14s Refine Results
  1. 1

    Xanthine urolithiasis: Inhibitors of xanthine crystallization. by Felix Grases, Antonia Costa-Bauza, Joan Roig, Adrian Rodriguez

    Published 2018-01-01
    “…OBJECTIVE:To identify in vitro inhibitors of xanthine crystallization that have potential for inhibiting the formation of xanthine crystals in urine and preventing the development of the renal calculi in patients with xanthinuria. …”
    Get full text
    Article
  2. 2

    Xanthine urolithiasis by Gargah Tahar, Essid Afif, Labassi Aymen, Hamzaoui Mourad, Lakhoua Mohamed

    Published 2010-01-01
    “…Hereditary xanthinuria type I, a defect of purine matabolism, results from a genetic deficiency of xanthine oxidase. It is an uncommon cause of stone formation in children. …”
    Get full text
    Article
  3. 3
  4. 4

    The mechanism and significance of the conversion of xanthine dehydrogenase to xanthine oxidase in mammalian secretory gland cells by Teruo Kusano, Tomoko Nishino, Ken Okamoto, Russ Hille, Takeshi Nishino

    Published 2023-02-01
    “…The conversion of xanthine dehydrogenase (XDH) to xanthine oxidase (XO) occurs only in mammalian species. …”
    Get full text
    Article
  5. 5
  6. 6
  7. 7
  8. 8

    Xanthine Oxidase—A Personal History by Russ Hille

    Published 2023-02-01
    Subjects: “…xanthine oxidase…”
    Get full text
    Article
  9. 9

    Xanthine oxidase inhibitors in asymptomatic hyperuricemia by O. V. Zhelyabina, M. S. Eliseev

    Published 2019-10-01
    “…Although the routine prophylactic urate-lowering therapy is not indicated in the vast majority of cases of AHU, there is growing evidence that this correction is necessary in some groups of patients. The use of xanthine oxidase (XO) inhibitors in a number of trials was accompanied by a reduction in the risk of CVD and by an improvement in renal function. …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13

    Xanthine scaffold: scope and potential in drug development by Nivedita Singh, Ashwinee Kumar Shreshtha, M.S. Thakur, Sanjukta Patra

    Published 2018-10-01
    “…Medicinal plants have been the basis for discovery of various important marketed drugs. Xanthine is one such lead molecule. Xanthines in various forms (caffeine, theophylline, theobromine, etc) are abode in tea, coffee, cocoa, chocolate etc. giving them popular recognition. …”
    Get full text
    Article
  14. 14
  15. 15

    The impact of xanthine oxidase (XO) on hemolytic diseases by Heidi M. Schmidt, Eric E. Kelley, Adam C. Straub

    Published 2019-02-01
    “…A key enzymatic source of these reactive species is the purine catabolizing enzyme, xanthine oxidase (XO) as the oxidation of hypoxanthine to xanthine and subsequent oxidation of xanthine to uric acid generates superoxide (O2•-) and hydrogen peroxide (H2O2). …”
    Get full text
    Article
  16. 16

    Xanthine oxidoreductase activity is correlated with hepatic steatosis by Chisako Yagi, Yoshiki Kusunoki, Taku Tsunoda, Takayo Murase, Takashi Nakamura, Keiko Osugi, Mana Ohigashi, Akiko Morimoto, Akio Miyoshi, Miki Kakutani-Hatayama, Kae Kosaka-Hamamoto, Manabu Kadoya, Kosuke Konishi, Takuhito Shoji, Hidenori Koyama

    Published 2022-07-01
    “…Abstract The enzyme xanthine oxidoreductase (XOR) catalyzes the synthesis of uric acid (UA) from hypoxanthine and xanthine, which are products of purine metabolism starting from ribose-5-phosphate. …”
    Get full text
    Article
  17. 17
  18. 18
  19. 19
  20. 20

    Some opportunities of using xanthine oxidase inhibitors by O. V. Zhelyabina, M. S. Eliseev

    Published 2019-03-01
    “…The review presents modern concepts of the role of xanthine oxidase (XO) in the pathogenesis of a number of diseases. …”
    Get full text
    Article